Site-specific oncology
Haemato-Oncology: Acute Leukaemia
Haemato-Oncology: Acute Leukaemia Seat open
This seat is specified, funded and unfilled. We publish it rather than implying the cover exists, because a name on a website that cannot see you is worse than an empty chair.
Scope of practice
Acute leukaemia, CNS prophylaxis, differentiation therapy and minimal residual disease.
How you can consult
- In person
- A scheduled clinic at Paschim Vihar.
- Virtual
- Video consultation, scheduled to your time zone.
- Board
- Sits on the molecular tumour board and votes on the recommendation.
- Written opinion
- Reviews and signs written second opinions.
Disease sites covered
- Department
- Site-specific oncology
- Board seat
- Panel member
What the post is
What you would actually be doing
A seat on the board
Not an occasional invitation. The quorum rule means the board does not sit without the relevant seat filled, so the commitment is real and so is the standing.
Your patients stay yours
Where a procedure is needed it happens at your facility. We bring the decision, the board and the molecular work.
Sessional, not salaried into idle time
Terms are discussed in the contracting conversation. We do not publish consultant remuneration.
Who you would be working alongside
The people already covering these disease sites. A seat is not a solo post: the board does not sit without the relevant seat filled, so the commitment is real and so is the standing.
Current panel on these sites
- Dr Bharat KwatraHead of Computational Precision Oncology · Chair, Molecular Tumour Board · Founder
- Physician Clinical Lead · Co-chair, Molecular Tumour BoardPhysician Clinical Lead · Co-chair, Molecular Tumour Board
- Genomic Interpretation Seat: Molecular Tumour BoardGenomic Interpretation Seat: Molecular Tumour Board
- Haemato-OncologyHaemato-Oncology